Associations - HRD + BRCA2 mutation

BIOMARKER:

HRD + BRCA2 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

HRD + BRCA2 mutation HRD + BRCA2 mutation	Prostate Cancer Prostate Cancer	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3
HRD + BRCA2 mutation HRD + BRCA2 mutation	Ovarian Cancer Ovarian Cancer	niraparib Sensitive: C3 – Early Trials niraparib Sensitive : C3
HRD + BRCA2 mutation HRD + BRCA2 mutation	Fallopian Tube Cancer Fallopian Tube Cancer	niraparib Sensitive: C3 – Early Trials niraparib Sensitive : C3
HRD + BRCA2 mutation HRD + BRCA2 mutation	Peritoneal Cancer Peritoneal Cancer	niraparib Sensitive: C3 – Early Trials niraparib Sensitive : C3